Show simple item record

dc.contributor.authorNational Health Library & Knowledge Service (NHLKS)
dc.contributor.authorHegarty, Ronan
dc.contributor.authorLee, Caitriona
dc.contributor.authorMorgan, Margaret
dc.contributor.authorEgan, Siobhan
dc.contributor.authorLeen, Brendan
dc.date.accessioned2020-05-08T11:32:26Z
dc.date.available2020-05-08T11:32:26Z
dc.date.issued2020-03-30
dc.identifier.urihttp://hdl.handle.net/10147/627609
dc.descriptionThe following information resources have been selected by the National Health Library and Knowledge Service Evidence Virtual Team in response to your question. The resources are listed in our estimated order of relevance to practicing healthcare professionals confronted with this scenario in an Irish context. In respect of the evolving global situation and rapidly changing evidence base, it is advised to use hyperlinked sources in this document to ensure that the information you are disseminating to the public or applying in clinical practice is the most current, valid and accurate.en_US
dc.language.isoenen_US
dc.publisherHealth Service Executiveen_US
dc.relation.ispartofseriesEvidence summariesen_US
dc.subjectCORONAVIRUSen_US
dc.subjectCOVID-19en_US
dc.subjectPHARMACOLOGYen_US
dc.subjectMEDICINESen_US
dc.subjectANALGESIAen_US
dc.subjectIBUPROFENen_US
dc.titleEvidence summary: Is it safe to use ibuprofen in the pharmacological treatment of a patient with COVID-19?en_US
dc.typeOtheren_US
refterms.dateFOA2020-05-08T11:32:27Z


Files in this item

Thumbnail
Name:
Evidence-Summary-COVID-19-Ibup ...
Size:
397.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record